Cell Cure Neurosciences Ltd.

POB 12247
Jerusalem
91121

Tel: 972-545-245-677
Fax: 972-2-642-9856

Show jobs for this employer

About Cell Cure Neurosciences Ltd.

Established in 2005, Cell Cure is located in Jerusalem, Israel on the campus of Hadassah Medical Center. Cell Cure’s mission is to become a leading supplier of human cell-based therapies for the treatment of retinal and neural degenerative diseases. Its technology platform is based on the manufacture of diverse cell products sourced from clinical-grade (GMP-compatible) human embryonic stem cells. Its current focus is the development of retinal pigment epithelial (RPE) cells for the treatment of age-related macular degeneration. Cell Cure’s major shareholders include BioTime, Inc.(NYSE MKT and TASE: BTX), HBL Hadasit Bio-Holdings Ltd., and Teva Pharmaceuticals Industries Ltd.
YEAR FOUNDED:
2005
LEADERSHIP:
CEO: Charles S. Irving
CSO: Benjamin Reubinoff

3 articles about Cell Cure Neurosciences Ltd.